FF-21101

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameFF-21101

Drug Alias Nameanti-CDH3 chimeric mAb radioconjugate (FUGIFILM)FF-21101

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibodyRadiation-emitting productsBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate

Mechanisms of ActionCadherin 3 modulators

TargetsCadherin 3

Therapy Area/IndicationsSolid tumoursHead and Neck NeoplasmsOvarian Neoplasms +[6]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesEuropeJapan

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesPerseus Proteomics Inc

China Registration ClassN/A

Develop Information

Active CompaniesFujifilm Holdings Corp

Inactive CompaniesN/A

Active IndicationsSolid tumoursHead and Neck NeoplasmsOvarian Neoplasms +[6]

Inactive IndicationsN/A

Other Information

ATC CodeN/A